(Jan. 4, 2023)Getting to the 'Point': Powerful Computing Helps Identify Potential New Treatments for Coronaviruses
A&S chemistry professor Atanu Acharya seeks to identify antibodies effective against all coronaviruses and variants.
(Jan. 3, 2023)Making a Difference at Moderna
Thanks to the A&S | Maxwell alumni connections program, two A&S grads are fighting evolving diseases.
(Oct. 28, 2022)Advancing Artificial Enzyme Engineering
A research team including chemists from Syracuse University create the fastest artificial enzyme ever reported thanks to a novel method of locating an enzyme’s “sweet spot.”
(April 29, 2022)Five NSF CAREER Awards a Record for A&S
Professors John Franck, Brett Jakubiak, David Kellen, Davoud Mozhdehi and Minghao Rostami have been awarded five-year CAREER grants to support their innovative research and educational outreach.
(Dec. 17, 2021)Michael Sponsler and Steluta Dinca Awarded NSF EAGER Grant
The grant will support their research with superconducting polyacetylene.
(Dec. 14, 2021)Chemist Timothy Korter Awarded Grant From Hitachi High-Technologies Corporation for Pharmaceutical Research
Korter's grant will support his work to interpret, analyze and model complex pharmaceuticals.
(Sept. 15, 2021)Taking the Guesswork Out of Nanoparticle Design
Professors Davoud Mozhdehi and Shikha Nangia are using machine learning to guide the design of stable nanoparticles.
(Aug. 9, 2021)A&S Chemist Awarded NIH Grant to Develop New Diabetes Drug
$2.4 million grant from the National Institutes of Health will explore how to remove the nausea, illness and weight loss associated with a class of Type 2 diabetes treatments.